Q2 2021 Holdings
Filed 2021-08-16 | 10 holdings | $530.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $530.4M | 9,699,925 | 99.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $98.9K | 3,504,624 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $54.6K | 2,200,778 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $42.9K | 2,303,310 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $35.4K | 2,608,167 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $26.0K | 411,471 | 0.0% |
| Impel Neuropharma Inc | COM | 45258K109 | $24.4K | 2,759,791 | 0.0% |
| Checkmate Pharmaceuticals in | COM | 162818108 | $21.9K | 3,673,374 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $11.6K | 3,059,123 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.1K | 161,897 | 0.0% |